ESR1 and breast carcinoma: Yin et al. developed estrone-modified glycol chitosan nanoparticles (GCNP-ES) for breast cancer treatment because estrogen receptor (ER) is overexpressed in breast cancer tissues compared to normal mammary glands [65].